(2S,4S)-4-Hydroxypyrrolidine-2-carboxylic acid hydrochloride, 95.0%, 25g

4-Nitroisoxazole, 95.0%, 5g

Benzyldimethylsilane, 5g

4-tert-Butoxycarbonylaminobutyric acid, 97.00%, 10g

2-((4-Fluorophenyl)amino)-4-methyl-1,3-thiazole-5-carboxylic acid, 95%, 10g

N-HEXANOYL-DL-HOMOSERINE LACTONE, 95.0%, 250mg

Medetomidine Hydrochloride>98.0%(T)(HPLC)100mg

3-(2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-6-YL)PROPANOIC ACID, 95.0%, 250mg

(1S,2R)-2-(Dibutylamino)-1-phenyl-1-propanol>98.0%(GC)(T)5g

N-(2,4-Dimethoxybenzyl)-5-fluoro-N-(6-fluoropyridin-2-yl)-2-oxo-2,3-dihydrobenzo[d]oxazole-6-sulfonamide, 97%, 1g

Báscula analítica y de precisión serie Entris® II Modelos con ajuste externo, no certificados, 0,001 g, 420 g, BCE423-1S (W)

2-Chloro-6-methylpyridin-3-amine, 97.0%, 10g

(S)-1-(3-METHYL-1,2,4-OXADIAZOL-5-YL)ETHANAMINE, 95.0%, 250mg